KRAS and neoplasm: (27) In a systemic autophagy inhibition model, where a dominant-negative Atg4b mutant was inducibly expressed, acute autophagy blockade in established Kras-driven pancreatic tumors led to substantial tumor regression, suggesting that both host-derived and tumor cell-autonomous autophagy contribute to tumorigenesis.